Compare NEPH & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEPH | EKSO |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.7M | 37.9M |
| IPO Year | 2004 | 2012 |
| Metric | NEPH | EKSO |
|---|---|---|
| Price | $3.65 | $11.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $9.50 |
| AVG Volume (30 Days) | 32.6K | ★ 55.1K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1000.00 | 41.76 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $18,789,000.00 | N/A |
| Revenue This Year | $11.24 | $81.23 |
| Revenue Next Year | $11.58 | $7.29 |
| P/E Ratio | $369.50 | ★ N/A |
| Revenue Growth | ★ 32.67 | N/A |
| 52 Week Low | $2.66 | $2.88 |
| 52 Week High | $6.42 | $13.50 |
| Indicator | NEPH | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 60.17 |
| Support Level | $3.64 | $8.30 |
| Resistance Level | $3.78 | $12.39 |
| Average True Range (ATR) | 0.28 | 0.86 |
| MACD | 0.03 | 0.15 |
| Stochastic Oscillator | 85.23 | 79.44 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.